A Cancer Center-managed facility, the Molecular Pathology Shared Resource continues to provide access to well characterized human normal and tumor tissues, macromolecule (DNA/RNA) extraction/quantification, and expert histopathology evaluation. This Shared Resource remains highly in demand with heavy utilization by members of the Herbert Irving Comprehensive Cancer Center (HICCC). Services provided include: ? Tissue Procurement, banking and distribution to investigators ? DNA/RNA extraction, banking and distribution to investigators for molecular biology studies ? Histology, tissue microarray construction and immunohistochemistry for investigator-initiated projects The tumor banking service includes the procurement, storage and distribution of normal and tumor samples from Columbia University Medical Center (CUMC). The bank follows CUMC IRB guidelines, and has multiple security layers to ensure sample safety. The macromolecular service provides DNA/RNA isolation and quantitation, assisting with ancillary techniques, such as tissue microdissection. The histology service provides a full array of tissue-based methods, including tissue grossing, processing, frozen section cutting, standardized and specialized histochemical staining. It also offers expert systematic histopathologic evaluation of human and experimental tissue samples, and assists in routine tissue microarray construction. In addition, it offers immunohistochemistry (IHC) and in situ hybridization (ISH) in order to define expression patterns. Future plans center on further developing and implementing novel techniques in image analysis and quantitative biomarker multiplexing at the microanatomical detail (""""""""systems pathology""""""""). The facility is also generating tissue pharmacodynamic studies to further define biological endpoints and valuable biomarkers to assist in clinical trials. Finally, working in close association with the Biomedical Informatics Resource, integration of biospecimen management, clinical and molecular data is pursued following caBIG guidelines, and using novel tools, such as caTissue (biospecimen management) and calntegrator (integration of clinicopathological and genomic data). During the last period of the CCSG* 30% of the investigators using the facility are Cancer Center members with peer-reviewed funding, with those members representing from 30% to 50% of the usage of the established services. The proposed total operating budget of the facility is $843,715, of which we are requesting $ 255,887 from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013696-39
Application #
8375775
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
39
Fiscal Year
2012
Total Cost
$190,790
Indirect Cost
$72,327
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Villasante, A; Sakaguchi, K; Kim, J et al. (2017) Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma. Theranostics 7:4099-4117
Ma, Kevin K; Lin, James; Boudreault, Katherine et al. (2017) PHENOTYPING CHOROIDEREMIA AND ITS CARRIER STATE WITH MULTIMODAL IMAGING TECHNIQUES. Retin Cases Brief Rep 11 Suppl 1:S178-S181
Kampers, Johanna; Orjuela-Grimm, Manuela; Schober, Tilmann et al. (2017) Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules. Leuk Lymphoma 58:633-638
Cabral, Thiago; DiCarlo, James E; Justus, Sally et al. (2017) CRISPR applications in ophthalmologic genome surgery. Curr Opin Ophthalmol 28:252-259
Velez, Gabriel; Bassuk, Alexander G; Colgan, Diana et al. (2017) Therapeutic drug repositioning using personalized proteomics of liquid biopsies. JCI Insight 2:
Dutta, Aditya; Panja, Sukanya; Virk, Renu K et al. (2017) Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5?-reductase Inhibition. Eur Urol 72:499-506
Chiang, Wei-Chieh; Chan, Priscilla; Wissinger, Bernd et al. (2017) Achromatopsia mutations target sequential steps of ATF6 activation. Proc Natl Acad Sci U S A 114:400-405
Marks, Lianna J; Oberg, Jennifer A; Pendrick, Danielle et al. (2017) Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience. Front Pediatr 5:265
Kanner, Scott A; Morgenstern, Travis; Colecraft, Henry M (2017) Sculpting ion channel functional expression with engineered ubiquitin ligases. Elife 6:
Wang, Tian; Tsang, Stephen H; Chen, Jeannie (2017) Two pathways of rod photoreceptor cell death induced by elevated cGMP. Hum Mol Genet 26:2299-2306

Showing the most recent 10 out of 263 publications